Cuprina Holdings Falls 22% After 112% Rally — Here's Why CUPR Stock Is Trending

Cuprina Holdings (NASDAQ: CUPR) surged 111.84% intraday to $8.41 after receiving FDA 510(k) clearance for MEDIFLY Maggots, a maggot debridement product for non-healing wounds. The stock subsequently fell 22.47% to $6.52 in after-hours trading. MEDIFLY Maggots is the first maggot debridement product using Lucilia cuprina species to receive FDA clearance, giving the Singapore-based biomedical company commercial rights to both maggot species used in the therapy.